US Patent Litigations are now available. Check here

Explore Britannia Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 5, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3174526Mar 22, 2023Composition Containing Apomorphine And A Divalent Metal Cation2